Competitive Intelligence
GvHD landscape and impact analysis
March 17, 20262.4K views
1
Objective
- To evaluate competitors and conduct impact analysis in chronic Graft versus Host Disease (cGvHD) space for a Phase-3 stem cell asset.
2
Approach
- Conducted a deep dive into the cGvHD space, its treatment algorithm and various stem cell therapies in this area
- Assessed inline and pipeline candidates for cGvHD Treatment and categorized them based on their MOA, stage of development, target patient pool, line of therapy and ROA
- Analyzed the impact of each asset based on probability of regulatory and clinical success
- Conducted detailed SWOT analysis of all key assets in the landscape
3
Outcome
- Summarized the unmet medical needs while managing cGvHD
- Identified potential threats for the client's Phase 3 asset based on comprehensive competitor profiles which included details on MOA, clinical profile and potential commercial profile
- Mapped order of entry of the key stem cell therapies
4
Client Benefits
- Our analysis provided an overview of cGvHD landscape outlining the key stem cell therapies
- Helped identify key differentiators against the competition
- Based on the findings, the client was able to assess market dynamics and build revenue projections
- Our analysis and report were instrumental in the client's strategic decision making with regards to the cGvHD market